Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-14
5:07 pm
Purchase
13GEntrada Therapeutics, Inc.
TRDA
Redmile Group LLC1,954,420
6.3%
1,954,420increase
(New Position)
View
2022-02-14
2:35 pm
Purchase
13GEntrada Therapeutics, Inc.
TRDA
PRICE T ROWE ASSOCIATES INC /MD/2,020,637
6.4%
2,020,637increase
(New Position)
View
2022-02-14
06:19 am
Purchase
13GEntrada Therapeutics, Inc.
TRDA
ROCHE FINANCE LTD2,813,525
9%
2,813,525increase
(New Position)
View
2022-02-08
12:03 pm
Purchase
13GEntrada Therapeutics, Inc.
TRDA
MRL Ventures Fund LLC1,739,768
5.6%
1,739,768increase
(New Position)
View
2022-02-04
09:17 am
Purchase
13GEntrada Therapeutics, Inc.
TRDA
WELLINGTON MANAGEMENT GROUP LLP3,114,006
9.98%
3,114,006increase
(New Position)
View
2021-12-16
5:23 pm
Unchanged
13DEntrada Therapeutics, Inc.
TRDA
BAKER BROS. ADVISORS LP4,704,419
15.1%
0
(Unchanged)
View
2021-11-12
4:30 pm
Purchase
13DEntrada Therapeutics, Inc.
TRDA
5AM Ventures V, L.P.4,409,687
14.8%
4,409,687increase
(New Position)
View
2021-11-12
4:07 pm
Purchase
13DEntrada Therapeutics, Inc.
TRDA
MPM BioVentures 2014 L.P.4,427,092
14.8%
4,427,092increase
(New Position)
View
2021-11-10
4:50 pm
Purchase
13GEntrada Therapeutics, Inc.
TRDA
BAKER BROS. ADVISORS LP4,704,419
15.1%
4,704,419increase
(New Position)
View